Abstract:GBM (Glioblastoma multiform) is the most malignant tumor type of the central nervous system and has poor diagnostic and clinical outcomes. LncRNAs (Long non-coding RNAs) have been reported to participate in multiple biological and pathological processes, but their underlying mechanism remains poorly understood. Here, we aimed to explore the role of the lncRNA HAS2-AS1 (HAS2 antisense RNA 1) in GBM. GSE103227 was analyzed, and qRT-PCR was performed to measure the expression of HAS2-AS1 in GBM. FISH (Fluorescence in situ hybridization) was performed to verify the localization of HAS2-AS1. The interaction between HAS2-AS1 and miR-137 (microRNA-137) was predicted by LncBook and miRcode followed by dual-luciferase reporter assays, and the relationships among HAS2-AS1, miR-137 and LSD1 (lysine-specific demethylase 1) were assessed by WB (western blot) and qRT-PCR. Colony formation and CCK-8 (cell counting kit-8) assays were performed as functional tests. In vivo, nude mice were used to confirm the function of HAS2-AS1. HAS2-AS1 expression was upregulated in GBM cell lines, and HAS2-AS1 was localized mainly in the cytoplasm. In vitro, high HAS2-AS1 expression promoted proliferation, and knockdown of HAS2-AS1 significantly inhibited proliferation. Furthermore, HAS2-AS1 functioned as a ceRNA (competing endogenous RNA) of miR-137, leading to the disinhibition of its downstream target LSD1. The miR-137 level was downregulated by HAS2-AS1 overexpression and upregulated by HAS2-AS1 knockdown. In a subsequent study, LSD1 expression was negatively regulated by miR-137, while miR-137 reversed the LSD1 expression levels caused by HAS2-AS1. These results were further supported by the nude mouse tumorigenesis experiment; compared with xenografts with high HAS2-AS1 expression, the group with low levels of HAS2-AS1 exhibited suppressed proliferation and better survival. We conclude that lncRNA HAS2-AS1 promotes proliferation by functioning as a miR-137 decoy to increase LSD1 levels and thus might be a possible biomarker for GBM.

LncRNA MALAT1/miR‐129 Axis Promotes Glioma Tumorigenesis by Targeting SOX2

Long Non-coding RNA MALAT1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124

Blocking Lncrna MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression

Downregulation of Lncrna-Malat1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S

Knockdown of SOX2OT Inhibits the Malignant Biological Behaviors of Glioblastoma Stem Cells Via Up-Regulating the Expression of Mir-194-5p and Mir-122

MALAT1 promotes proliferation, migration, and invasion of MG63 cells by upregulation of TGIF2 via negatively regulating miR-129 .

Involvement of Microrna-1297, a New Regulator of HMGA1, in the Regulation of Glioma Cell Growth in Vivo and in Vitro.

SOX9+ malignant cells define a poor prognosis subtype of Glioma with tumor-associated macrophage recruitment

Lncrna Has2-As1 Promotes Glioblastoma Proliferation By Sponging Mir-137

MALAT1 Promotes Osteosarcoma Development by Regulation of HMGB1 Via Mir-142-3p and Mir-129-5p

Malat1 Is A Prognostic Factor In Glioblastoma Multiforme And Induces Chemoresistance To Temozolomide Through Suppressing Mir-203 And Promoting Thymidylate Synthase Expression

Long Noncoding RNA SNHG3 Promotes Glioma Tumorigenesis by Sponging Mir‐485‐5p to Upregulate LMX1B Expression

Inhibition of TDP43-Mediated SNHG12-miR-195-SOX5 Feedback Loop Impeded Malignant Biological Behaviors of Glioma Cells.

The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis

Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells

Long non-coding RNA COX10-AS1 promotes glioma progression by competitively binding miR-1-3p to regulate ORC6 expression

LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression

Microrna-497-5p Targeted Sox9 To Inhibit Proliferation, Migration And Invasion Of Glioma Cells

LncRNA MALAT-1 regulates expression of miR-205 and affects growth and migration of non-small cell lung cancer cells

LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma Via Targeting Mir-128-3p/szrd1 Axis

Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR‐499a‐5p/LMX1A/NLRC5 pathway